|
TCEANC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.6370000344732E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27770002858563E-09 |
| Normal-vs-Stage2 |
5.597600E-03 |
| Normal-vs-Stage3 |
4.684200E-03 |
| Normal-vs-Stage4 |
2.61760000008771E-07 |
| Stage1-vs-Stage2 |
1.034590E-01 |
| Stage1-vs-Stage3 |
2.821800E-01 |
| Stage1-vs-Stage4 |
9.784000E-02 |
| Stage2-vs-Stage3 |
8.059800E-01 |
| Stage2-vs-Stage4 |
6.278900E-03 |
| Stage3-vs-Stage4 |
1.433820E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14020000108184E-08 |
| Normal-vs-AfricanAmerican |
6.98439999946565E-07 |
| Normal-vs-Asian |
1.116320E-03 |
| Caucasian-vs-AfricanAmerican |
8.890000E-01 |
| Caucasian-vs-Asian |
6.165800E-01 |
| AfricanAmerican-vs-Asian |
6.692200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.78168590991845E-12 |
| Normal-vs-Female |
1.175920E-02 |
| Male-vs-Female |
1.03200000001191E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.25680000000006E-05 |
| Normal-vs-Extreme_Weight |
3.39740013899359E-10 |
| Normal-vs-Obese |
3.42480000026235E-07 |
| Normal-vs-Extreme_Obese |
6.02269999999683E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.086600E-01 |
| Normal_Weight-vs-Obese |
8.045400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.658800E-01 |
| Extreme_Weight-vs-Obese |
2.558200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.417400E-01 |
| Obese-vs-Extreme_Obese |
3.885000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.836440E-04 |
| Normal-vs-Age(41-60Yrs) |
2.20519999999391E-05 |
| Normal-vs-Age(61-80Yrs) |
1.71419989314359E-10 |
| Normal-vs-Age(81-100Yrs) |
1.05859999999236E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.871200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.742000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.284000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.803200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.637800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.792800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.4248381080838E-12 |
| Normal-VS-Type2 PRCC |
4.43760000001792E-06 |
| Normal-VS-KIRP CIMP |
1.566590E-04 |
| Normal-VS-Unclassified PRCC |
2.217300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.400800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.056000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.197700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.814400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.433200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.869800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.50220000006263E-07 |
| Normal-vs-N1 |
6.804700E-03 |
| Normal-vs-N2 |
1.041240E-01 |
| N0-vs-N1 |
6.045000E-01 |
| N0-vs-N2 |
5.196400E-01 |
| N1-vs-N2 |
8.316400E-01 |
|
|
